Ivoclar Vivadent executes Patent License Agreement with Henry Schein

Schaan, Liechtenstein – 16 May 2014

On May 15, 2014 Ivoclar Vivadent announced that it has recently licensed several of its patents to Henry Schein, Inc. The royalty-bearing license agreement enables Henry Schein to use the rights protected by United States Patent Nos. 7,604,759 and 8,141,217, and several related foreign patents that cover zirconium oxide dental blanks and methods of processing those blanks. Ivoclar Vivadent is committed to asserting and defending its intellectual property rights, in particular in the area of dental ceramics.

About Ivoclar Vivadent
Ivoclar Vivadent, headquartered in Schaan, Liechtenstein, is one of the world's leading manufacturers of innovative material systems for high-quality dental applications. The company's success is based on a comprehensive portfolio of products and systems, strong research and development capabilities and a clear commitment to training and further education. The company has wholly owned subsidiaries in 24 countries, and it employs over 3,000 people worldwide. More information about Ivoclar Vivadent is available at www.ivoclarvivadent.com.